Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Valente

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
BMC Cancer|March 1, 2014
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMSRoberta Ciarapica, Elena Carcarino, Laura Adesso, et al.
Journal of Medicinal Chemistry|January 7, 2014
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cellsSergio Valente, Yiwei Liu, Michael Schnekenburger, et al.
Journal of Medicinal Chemistry|December 23, 2015
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer CellsSergio Valente, Paolo Mellini, Francesco Spallotta, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Journal of Medicinal Chemistry|June 2, 2021
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED InteractionDaohai Du, Dandan Xu, Licheng Zhu, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2024
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodelingMichela Terri, Pilar Sandoval, Giulio Bontempi, et al.
European Journal of Medicinal Chemistry|December 22, 2018
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cellsGiulia Stazi, Cecilia Battistelli, Valentina Piano, et al.
Journal of Fungi (Basel, Switzerland)|October 28, 2025
Pediatric Coccidioidal Meningitis: A Systematic Review and Proportional Synthesis of Cases Reported in the Fluconazole Era (2000-2025)Maria F De la Cerda-Vargas, Pedro Navarro-Dominguez, Elizabeth Meza-Mata, et al.
Cell Death Discovery|August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaksMatteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
BMC Cancer|March 1, 2014
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMSRoberta Ciarapica, Elena Carcarino, Laura Adesso, et al.
Journal of Medicinal Chemistry|January 7, 2014
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cellsSergio Valente, Yiwei Liu, Michael Schnekenburger, et al.
Journal of Medicinal Chemistry|December 23, 2015
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer CellsSergio Valente, Paolo Mellini, Francesco Spallotta, et al.
Clinical Epigenetics|May 8, 2019
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cellsClemens Zwergel, Michael Schnekenburger, Federica Sarno, et al.
Nature Chemical Biology|October 26, 2023
Targeting ROS production through inhibition of NADPH oxidasesJoana Reis, Christoph Gorgulla, Marta Massari, et al.
Journal of Medicinal Chemistry|June 2, 2021
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED InteractionDaohai Du, Dandan Xu, Licheng Zhu, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2024
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodelingMichela Terri, Pilar Sandoval, Giulio Bontempi, et al.
European Journal of Medicinal Chemistry|December 22, 2018
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cellsGiulia Stazi, Cecilia Battistelli, Valentina Piano, et al.
Journal of Fungi (Basel, Switzerland)|October 28, 2025
Pediatric Coccidioidal Meningitis: A Systematic Review and Proportional Synthesis of Cases Reported in the Fluconazole Era (2000-2025)Maria F De la Cerda-Vargas, Pedro Navarro-Dominguez, Elizabeth Meza-Mata, et al.
Cell Death Discovery|August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaksMatteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Pageof 16